diabetic%20ketoacidosis%20-and-%20hyperosmolar%20hyperglycemic%20state
DIABETIC KETOACIDOSIS & HYPEROSMOLAR HYPERGLYCEMIC STATE
Diabetic ketoacidosis is characterized by having blood glucose >13.9 mmol/L, arterial pH <7.3 in adults or venous pH <7.3 in pediatrics, bicarbonate <15 mEg/L, moderate ketonuria or ketonemia and anion gap >14.
Hyperosmolar Hyperglycemic state in adults is described as having blood glucose >33.3 mmol/L, arterial pH >7.3, bicarbonate >15 mEq/L, mild ketonuria or ketonemia, effective serum osmolality >320 mOsm/kg and variable anion gap.
While hyperosmolar Hyperglycemic state in pediatric patients have blood glucose >33.3 mmol/L, venous pH >7.3, bicarbonate >15 mEq/L and altered mental status or severe dehydration.

Monitoring

Adult diabetic ketoacidosis (DKA)

  • Check glucose, blood urea nitrogen (BUN), creatinine, & electrolytes every 2-4 hours until stable
  • Continue to investigate precipitating causes & treat appropriately

Criteria for Resolution of DKA:

  • Blood glucose <200 mg/dL
  • Venous pH >7.3
  • Bicarbonate ≥15 mEq/L

After Resolution of DKA:

  • If patient is nothing by mouth/non per os (NPO), continue intravenous (IV) insulin & supplement w/ Regular insulin subcutaneous (SC) as required every 4 hours

Once patient is able to eat:

  • Start multidose insulin regimen & adjust as required
  • IV insulin should be continued for 1-2 hours after SC insulin is started

Adult hyperosmolar hyperglycemic state (HHS)

  • Check BUN, creatinine, electrolytes, & glucose every 2-4 hours until stable
  • Continue to investigate precipitating causes & treat appropriately

After Resolution of HHS:

  • If patient is NPO continue IV insulin & supplement w/ SC insulin as required

Once patient is able to eat:

  • Start multidose insulin regimen (such as SC), or give as previous treatment & check metabolic control

Pediatric DKA & HHS

  • Check glucose & electrolytes every 2-4 hours until stable
  • Continue to investigate precipitating causes & treat appropriately

After Resolution of DKA:

  • Start SC insulin (0.5-1 U/kg/day)
    • Give 2/3 of the total daily dose in the AM (1/3 short-acting & 2/3 of dose intermediate-acting insulin)
    • Give 1/3 of total daily dose in the PM (1/2 short-acting & 1/2 of dose intermediate-acting insulin)
  • Or give 0.1-0.25 U/kg SC of Regular insulin every 6-8 hours for the first 24 hours to determine insulin requirements
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
28 Apr 2018
Treatment with teriparatide increases periostin secretion, but it is unclear whether such increase facilitates the effect of the drug on bone, reports a recent study.
Jairia Dela Cruz, 03 Apr 2018
A small cohort study presented at the Royal College of Obstetricians & Gynaecologists (RCOG) World Congress 2018 has reported a 5-year diabetic ketoacidosis (DKA) incidence rate of 4.16 percent in pregnant women with type 1 diabetes mellitus (T1DM), with generally good maternal and neonatal outcomes.
24 Apr 2018
A subclinical inflammatory state resulting from increased adiposity and metabolic dysfunction appears to contribute to breast cancer pathogenesis in Asian women, a Taiwan study has found.
25 Apr 2018
Dietary glycaemic index (GI) or glycaemic load (GL) does not appear to have any significant effect on serum concentrations of inflammatory cytokines, including high-sensitivity C-reactive protein (hs-CRP), leptin, interleukin 6 (IL-6) and tumour necrosis factor α (TNF-α) in adults, reports a new study.